Asuragen Licenses MicroRNA IP From Rockefeller University | GenomeWeb
NEW YORK (GenomeWeb News) – Asuragen licensed microRNA sequences from Rockefeller University to develop early cancer detection tools, the company said today.
Under the semi-exclusive agreement, Asuragen will have access to microRNAs identified by a group led by Thomas Tuschl. These microRNAs are involved with human diseases like diabetes and cancer.
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.